DNAJA4 and alveolar rhabdomyosarcoma: Promoter hypermethylation of DNAJA4 has also been reported in several other diseases, such as paediatric embryonal and alveolar rhabdomyosarcomas, Ewing sarcoma, and oral leukoplakia [40–42].